Project description
Retinal screening device for earlier, easier diabetes diagnosis
Most of us take our sight for granted, but a growing population is at risk of severe vision impairment and even blindness, in large part due to the growing incidence of diabetes and the potential accompanying development of diabetic retinopathy. As with many conditions and diseases, early diagnosis and treatment can significantly improve outcome. However, current screening methods are expensive, require highly trained professional expertise, and are largely inaccessible to patients in developing countries. The EU-funded iScan project has developed an easy and affordable point-of-care retinal screening device that could be used by primary care physicians or even pharmacists. Integrating a camera, image-processing software, machine learning, and artificial intelligence, the solution promises to significantly increase early retinal screening and enhance outcomes for millions.
Objective
Oivi’s mission is to provide affordable eye care for all. Our vision is to eliminate unnecessary blindness by providing a lowcost camera for retinal (fundus) photography, with fully automated image capture and diagnostics. Our goal is for Oivi to become the point-of-care device for preventative eye screening, with diabetic retinopathy (DR) as our first area of focus. DR affects >160 million people worldwide and is the most common cause of blindness among people with diabetes. However, early detection and intervention can successfully prevent vision-loss from DR in 95% of the cases. A major financial and social burden is caused by DR, and these costs can be vastly reduced through a solution like Oivi.
Current solutions for DR screening are often expensive and require extensive training, limiting accessibility for patients, especially in developing countries. Oivi’s device is a unique combination of automated, easy-to-use, low-cost and integrated AI diagnostics solutions in a highly portable design. These features will allow healthcare professionals and pharmacists to carry out screening anywhere with no training and address the unmet need for early screening in primary care.
Oivi will be particularly relevant for low- and middle-income countries like India, but also for the European market. Oivi envisions to move the standard of care of diagnosis of DR from the ophthalmologists office to primary care level. This leads to a smooth patient flow between primary care and specialists and reduces patient fall out. Also, pharmacies provide excellent coverage and can make DR screening as common as blood glucose tests.
Oivi will use the iScan project as a vital step to prepare the company’s business strategy and mature the device and its diagnostic functionalities and to align it with end-user needs, regulatory standards and IP strategy. The iScan project is expected to untap a large business opportunity for Oivi, in the first application – DR screening and diagnosis.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences computer and information sciences artificial intelligence
- engineering and technology electrical engineering, electronic engineering, information engineering electronic engineering sensors optical sensors
- medical and health sciences clinical medicine endocrinology diabetes
- medical and health sciences clinical medicine ophthalmology retinopathy
- medical and health sciences basic medicine pharmacology and pharmacy
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3. - PRIORITY 'Societal challenges
See all projects funded under this programme -
H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-EIC-SMEInst-2018-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
0349 Oslo
Norway
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.